CB:NYSEChubb Limited Analysis
Data as of 2026-05-25 - not real-time
$327.89
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Chubb Limited (CB) is trading at $327.89, comfortably above its 20‑day (324.70) and 50‑day (326.34) simple moving averages, indicating short‑term momentum. The MACD histogram is positive (0.96) and the signal line is bearish, yielding a bullish MACD signal, while the RSI sits at a neutral 53, suggesting room for further upside. Technical support sits near $315 and resistance near $334, placing the current price just below the next resistance level. Fundamentally, the stock trades at a forward PE of 11.2 versus an industry average of 16.8, highlighting a clear value discount. Revenue grew 10.2% YoY, margins remain solid (gross 31%, operating 20.6%, profit 18.5%) and free cash flow exceeds $12.6 B, underscoring robust profitability. The dividend has been raised 5.2% to $4.08 with a low payout ratio of 13.7%, supporting a sustainable 1.24% yield.
A recent $1 B senior note issuance at 5.30% and a $7.5 B share‑repurchase program signal confidence from management and provide additional capital flexibility. Shareholder sentiment is reinforced by a headline naming CB as a top fundamental stock among billionaires, adding qualitative momentum. The DCF‑derived fair value of $605.6 implies an upside of roughly 5% relative to current pricing, while the analyst consensus target median of $340 suggests modest near‑term appreciation. Beta is near zero and 30‑day volatility is moderate at 16.7%, indicating limited price swings in the broader market context. With a strong balance sheet—$7.5 B cash versus $25.1 B debt and a debt‑to‑equity of 31.5%—the company is well‑positioned to weather underwriting cycles. Overall, the combination of undervaluation, dividend stability, and defensive industry characteristics makes CB a compelling buy across horizons.
A recent $1 B senior note issuance at 5.30% and a $7.5 B share‑repurchase program signal confidence from management and provide additional capital flexibility. Shareholder sentiment is reinforced by a headline naming CB as a top fundamental stock among billionaires, adding qualitative momentum. The DCF‑derived fair value of $605.6 implies an upside of roughly 5% relative to current pricing, while the analyst consensus target median of $340 suggests modest near‑term appreciation. Beta is near zero and 30‑day volatility is moderate at 16.7%, indicating limited price swings in the broader market context. With a strong balance sheet—$7.5 B cash versus $25.1 B debt and a debt‑to‑equity of 31.5%—the company is well‑positioned to weather underwriting cycles. Overall, the combination of undervaluation, dividend stability, and defensive industry characteristics makes CB a compelling buy across horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and price above short‑term SMAs
- Support near $315 with resistance at $334 offering upside
- Strong dividend increase and low payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Consensus target median $340 indicating near‑term upside
- $7.5 B share buyback enhancing shareholder returns
- Revenue growth ~10% and solid cash generation
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- DCF fair value $605 suggests long‑term undervaluation
- Sustainable dividend with low payout and growth
- Defensive insurance sector with low beta and strong balance sheet
Key Metrics & Analysis
Financial Health
Revenue Growth10.20%
Profit Margin18.53%
P/E Ratio11.6
ROE15.43%
ROA3.36%
Debt/Equity31.46
P/B Ratio1.7
Op. Cash Flow$15.2B
Free Cash Flow$12.6B
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI53.0
Support$315.04
Resistance$334.03
MA 20$324.70
MA 50$326.34
MA 200$304.22
MACDBullish
VolumeStable
Fear & Greed Index91.61
Valuation
Fair Value$605.61
Target Price$345.26
Upside/Downside5.30%
GradeUndervalued
TypeBlend
Dividend Yield1.24%
Risk Assessment
Beta-0.05
Volatility16.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.